Naltrexone/Bupropion Reduced Food Intake in Binge-Eating Lab Study
Lisdexamfetamine remains the only FDA-approved medication for binge-eating disorder — a serious condition affecting roughly 1.2% of adults. A 2026 human laboratory study by McKee and colleag…
Read article